BioIVT, a Baltimore, MD-based research partner and biospecimen solutions provider for drug and diagnostic development, acquired ZenBio, a Durham, NC-based company which specializes in advanced cell products and services.
The amount of the deal was not disclosed.
Together, BioIVT and ZenBio will offer an expanded portfolio of skin-based expertise, primary cell and exosome isolation, as well as blood products for pharmaceutical and cosmetics companies.
ZenBio is a science-focused company specializing in biospecimens and related services with scientific expertise and flexibility to meet researchers’ needs.
BioIVT accelerates medical innovations by delivering personalized biospecimen solutions and research services to the life science and diagnostic industries. It specializes in control and disease state samples including human and animal tissues or preparations, ADME-Tox products and research services, cell and gene therapy products, blood, and other biofluids. Its portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples.
FinSMEs
21/08/2024